As of 20/09/2023
Index Information
Index Details
The index tracks securities at the cross-roads of medicine and technology which are shaping the future of healthcare. These include over 100 global companies from the following 10 sub-themes: robotics; nanotechnology; genome sequencing; healthcare trackers; biological engineering; bioinformatics; neuroscience; medical devices; telemedicine and healthcare analytics.
Methodology
- Starting Universe: Stocks, ADRs and GDRs from developed and emerging markets
-
Investibility Screening: Capitalisation and liquidity screen. Min market cap of $500m. ADTV over $2m. Minimum 10% free float
-
Constituent Analysis: Companies revenues are analysed against 10 Healthcare Technology Categories
-
Constituent Selection: Companies that derive more than 50% of revenues from Innovative Healthcare activities are selected
-
Equal Weighting: Constituents are equally weighted at the semi-annual rebalance
-
Calculation: Indxx Advanced Life Sciences and Smart Healthcare Index calculation every 15 seconds. Rebalance March and September
To view the Methodology
click here.